GCIMpac Group reports strong start to 2024, on track to meet full-year expectations
Industry 4.0 is one of the hottest themes in manufacturing, not only allowing brand owners to reduce unit costs and downtime, but also materially lift productivity and ROIs.
However, achieving these benefits is not simple. Indeed, it typically involves using engineering experts like () , a specialist provider of full line, high-speed packaging and automation solutions to design, build, install, optimise and/or service equipment in both existing and new factories.
Today, the company said that after a strong close to 2023, momentum had continued into 2024, with YTD sales and adjusted PBT both above prior period levels.
Sure some smaller firms are struggling a little to finance new machinery due to the higher interest rates. Yet equally, has robust revenue cover for the rest of the year and serves a host of blue chip customers, including Nestlé, GSK, CooperVision, Kellogg’s, Diageo, Dexcom, Mars, and J&J.
This means results are on track to hit full-year expectations (H2-weighted as usual) with Shore Capital forecasting adjusted PBT of £10.5m (vs £7.1m LY) and 38.7p EPS (25.9p) on turnover up 5% to £120m. There will be a small cash outflow too in H1, followed by an opposite inflow in H2 as working capital unwinds.
This is just the start though.
Further out, the Board is targeting 10% EBIT margins and LFL top-line growth of 10% across the cycle - which will be achieved via a combination of market share gains (TAM $65bn-$70bn), operational excellence, a broadening of customer base, and innovation.
Elsewhere in clean energy, the group secured a £1.2m contract in April to help build a pilot plant for 's planned solid state battery project Goliath, whilst investors could also hear soon about progress wrt FREYR Battery's cell automation plans.
Finally in terms of valuation, Shore Capital has a fair value of between 500p to 600p/share.
Follow News & Updates from Mpac Group:
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.